-
Je něco špatně v tomto záznamu ?
Autosomal dominant Zellweger spectrum disorder caused by de novo variants in PEX14 gene
HR. Waterham, J. Koster, MS. Ebberink, P. Ješina, J. Zeman, L. Nosková, S. Kmoch, P. Devic, D. Cheillan, RJA. Wanders, S. Ferdinandusse
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- alely MeSH
- lidé MeSH
- peroxizomy genetika metabolismus MeSH
- proteiny genetika MeSH
- transport proteinů fyziologie MeSH
- Zellwegerův syndrom * genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
PURPOSE: Zellweger spectrum disorders (ZSDs) are known as autosomal recessive disorders caused by defective peroxisome biogenesis due to bi-allelic pathogenic variants in any of at least 13 different PEX genes. Here, we report 2 unrelated patients who present with an autosomal dominant ZSD. METHODS: We performed biochemical and genetic studies in blood and skin fibroblasts of the patients and demonstrated the pathogenicity of the identified PEX14 variants by functional cell studies. RESULTS: We identified 2 different single heterozygous de novo variants in the PEX14 genes of 2 patients diagnosed with ZSD. Both variants cause messenger RNA mis-splicing, leading to stable expression of similar C-terminally truncated PEX14 proteins. Functional studies indicated that the truncated PEX14 proteins lost their function in peroxisomal matrix protein import and cause increased degradation of peroxisomes, ie, pexophagy, thus exerting a dominant-negative effect on peroxisome functioning. Inhibition of pexophagy by different autophagy inhibitors or genetic knockdown of the peroxisomal autophagy receptor NBR1 resulted in restoration of peroxisomal functions in the patients' fibroblasts. CONCLUSION: Our finding of an autosomal dominant ZSD expands the genetic repertoire of ZSDs. Our study underscores that single heterozygous variants should not be ignored as possible genetic cause of diseases with an established autosomal recessive mode of inheritance.
Amsterdam Gastroenterology Endocrinology Metabolism Amsterdam The Netherlands
Amsterdam Reproduction and Development Amsterdam The Netherlands
Centre Hospitalier Universitaire de Lyon CHU Lyon·U 301 Hopital Neurologique Bron France
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24000902
- 003
- CZ-PrNML
- 005
- 20240213093448.0
- 007
- ta
- 008
- 240109s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.gim.2023.100944 $2 doi
- 035 __
- $a (PubMed)37493040
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Waterham, Hans R $u Amsterdam UMC - AMC, Department of Laboratory Medicine, Laboratory Genetic Metabolic Diseases, Amsterdam, The Netherlands; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands; Amsterdam Reproduction & Development, Amsterdam, The Netherlands; United for Metabolic Diseases, The Netherlands. Electronic address: h.r.waterham@amsterdamumc.nl
- 245 10
- $a Autosomal dominant Zellweger spectrum disorder caused by de novo variants in PEX14 gene / $c HR. Waterham, J. Koster, MS. Ebberink, P. Ješina, J. Zeman, L. Nosková, S. Kmoch, P. Devic, D. Cheillan, RJA. Wanders, S. Ferdinandusse
- 520 9_
- $a PURPOSE: Zellweger spectrum disorders (ZSDs) are known as autosomal recessive disorders caused by defective peroxisome biogenesis due to bi-allelic pathogenic variants in any of at least 13 different PEX genes. Here, we report 2 unrelated patients who present with an autosomal dominant ZSD. METHODS: We performed biochemical and genetic studies in blood and skin fibroblasts of the patients and demonstrated the pathogenicity of the identified PEX14 variants by functional cell studies. RESULTS: We identified 2 different single heterozygous de novo variants in the PEX14 genes of 2 patients diagnosed with ZSD. Both variants cause messenger RNA mis-splicing, leading to stable expression of similar C-terminally truncated PEX14 proteins. Functional studies indicated that the truncated PEX14 proteins lost their function in peroxisomal matrix protein import and cause increased degradation of peroxisomes, ie, pexophagy, thus exerting a dominant-negative effect on peroxisome functioning. Inhibition of pexophagy by different autophagy inhibitors or genetic knockdown of the peroxisomal autophagy receptor NBR1 resulted in restoration of peroxisomal functions in the patients' fibroblasts. CONCLUSION: Our finding of an autosomal dominant ZSD expands the genetic repertoire of ZSDs. Our study underscores that single heterozygous variants should not be ignored as possible genetic cause of diseases with an established autosomal recessive mode of inheritance.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a peroxizomy $x genetika $x metabolismus $7 D020675
- 650 _2
- $a transport proteinů $x fyziologie $7 D021381
- 650 _2
- $a proteiny $x genetika $7 D011506
- 650 12
- $a Zellwegerův syndrom $x genetika $7 D015211
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Koster, Janet $u Amsterdam UMC - AMC, Department of Laboratory Medicine, Laboratory Genetic Metabolic Diseases, Amsterdam, The Netherlands
- 700 1_
- $a Ebberink, Merel S $u Amsterdam UMC - AMC, Department of Laboratory Medicine, Laboratory Genetic Metabolic Diseases, Amsterdam, The Netherlands
- 700 1_
- $a Ješina, Pavel $u Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General Faculty Hospital, Prague 2, Czech Republic
- 700 1_
- $a Zeman, Jiri $u Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General Faculty Hospital, Prague 2, Czech Republic
- 700 1_
- $a Nosková, Lenka $u Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General Faculty Hospital, Prague 2, Czech Republic
- 700 1_
- $a Kmoch, Stanislav $u Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General Faculty Hospital, Prague 2, Czech Republic
- 700 1_
- $a Devic, Perrine $u Centre Hospitalier Universitaire de Lyon, CHU Lyon·U 301, Hopital Neurologique, Bron, France
- 700 1_
- $a Cheillan, David $u Service Biochimie et Biologie Moléculaire Grand Est, UM Pathologies Métaboliques, Erythrocytaires et Dépistage Périnatal, Centre de Biologie et de Pathologie Est, Groupement Hospitalier Est - Hospices Civils de Lyon, Bron Cedex, France
- 700 1_
- $a Wanders, Ronald J A $u Amsterdam UMC - AMC, Department of Laboratory Medicine, Laboratory Genetic Metabolic Diseases, Amsterdam, The Netherlands; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands; Amsterdam Reproduction & Development, Amsterdam, The Netherlands; United for Metabolic Diseases, The Netherlands
- 700 1_
- $a Ferdinandusse, Sacha $u Amsterdam UMC - AMC, Department of Laboratory Medicine, Laboratory Genetic Metabolic Diseases, Amsterdam, The Netherlands; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands
- 773 0_
- $w MED00186213 $t Genetics in medicine $x 1530-0366 $g Roč. 25, č. 11 (2023), s. 100944
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37493040 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213093445 $b ABA008
- 999 __
- $a ok $b bmc $g 2049490 $s 1210596
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 25 $c 11 $d 100944 $e 20230723 $i 1530-0366 $m Genetics in medicine $n Genet Med $x MED00186213
- LZP __
- $a Pubmed-20240109